NCT00002937View on ClinicalTrials.gov

Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 30, 1996

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
Breast Cancer
Interventions
DRUG

paclitaxel

DRUG

valspodar

Trial Locations (4)

91010

Beckman Research Institute, City of Hope, Duarte

95817

University of California Davis Cancer Center, Sacramento

90033-0800

USC/Norris Comprehensive Cancer Center, Los Angeles

M4N 3M5

Toronto Sunnybrook Regional Cancer Centre, Toronto

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT00002937 - Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter